Donaldson Capital Management LLC decreased its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 36.3% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 69,982 shares of the financial services provider's stock after selling 39,888 shares during the period. Donaldson Capital Management LLC's holdings in Aflac were worth $7,781,000 as of its most recent filing with the SEC.
Several other hedge funds have also added to or reduced their stakes in the stock. Roxbury Financial LLC purchased a new position in Aflac in the 4th quarter worth approximately $948,000. Proficio Capital Partners LLC purchased a new position in Aflac in the 4th quarter worth approximately $192,000. Next Level Wealth Planning LLC purchased a new position in Aflac in the 4th quarter worth approximately $318,000. Strategic Financial Concepts LLC grew its stake in Aflac by 2,210.3% in the 4th quarter. Strategic Financial Concepts LLC now owns 158,535 shares of the financial services provider's stock worth $164,000 after buying an additional 151,673 shares in the last quarter. Finally, Empowered Funds LLC boosted its stake in shares of Aflac by 10.0% in the 4th quarter. Empowered Funds LLC now owns 38,039 shares of the financial services provider's stock valued at $3,935,000 after purchasing an additional 3,454 shares in the last quarter. Institutional investors own 67.44% of the company's stock.
Insider Activity at Aflac
In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the transaction, the director now directly owns 26,096 shares in the company, valued at $2,786,791.84. This trade represents a 3.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Masatoshi Koide sold 37,000 shares of the firm's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total value of $3,906,830.00. Following the transaction, the director now owns 70,992 shares of the company's stock, valued at $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock worth $4,304,295 in the last three months. 0.90% of the stock is owned by company insiders.
Analyst Ratings Changes
A number of research firms recently commented on AFL. Raymond James lowered their price target on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating for the company in a report on Thursday, May 29th. Keefe, Bruyette & Woods upped their price target on shares of Aflac from $104.00 to $106.00 and gave the company a "market perform" rating in a report on Wednesday, May 7th. Wall Street Zen lowered shares of Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Wells Fargo & Company upped their price target on shares of Aflac from $102.00 to $103.00 and gave the company an "equal weight" rating in a report on Tuesday, May 6th. Finally, Piper Sandler upped their price objective on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average target price of $104.93.
Read Our Latest Research Report on AFL
Aflac Trading Up 1.3%
Shares of AFL traded up $1.31 during midday trading on Thursday, reaching $102.66. The company had a trading volume of 1,800,578 shares, compared to its average volume of 2,109,931. The firm has a 50 day simple moving average of $105.04 and a 200-day simple moving average of $105.68. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The stock has a market cap of $55.50 billion, a PE ratio of 10.69, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82. Aflac Incorporated has a 1-year low of $86.46 and a 1-year high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, April 30th. The financial services provider reported $1.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.67 by ($0.01). The business had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. Aflac had a return on equity of 16.20% and a net margin of 28.76%. The firm's revenue for the quarter was down 37.5% compared to the same quarter last year. During the same period in the previous year, the business posted $1.66 earnings per share. Research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.
Aflac Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were issued a dividend of $0.58 per share. This represents a $2.32 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is 36.25%.
Aflac Company Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles

Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.